Approval · Notice of Compliance 29122 · 2022
NUBEQA: Notice of Compliance 29122
Issued September 29, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29122
- Date
- September 29, 2022
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Priority
- Reason
- New indication.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUBEQA | Not yet assigned | — |
Medicinal ingredients
- DAROLUTAMIDE 300 MG per TAB